MALLORI SMITH: Open Payments
NPI 1730607615 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 30 payments from 11 companies in 2025. Trend: 2023 $406 · 2024 $344 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| PFIZER INC. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: UBRELVY, CAPLYTA, FARXIGA, QULIPTA, REXULTI, PREVNAR 20, Sunosi, Leqembi.
Industry payments across KS — which companies pay providers there.
